|
|
Article: New Analysis Demonstrates Additional Benefits of Clodronate as an Adjuvant Therapy For Breast Cancer; - Clodronate Use Reduced the Occurrence of Bone Metastases and Also Reduced Skeletal Complications in Patients who Developed Bone Metastases -.
- Article from:
- PR Newswire
- Article date:
- December 9, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN ANTONIO, Dec. 9 /PRNewswire/ -- A new analysis of data from a large- scale study presented today at the 27th Annual Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium demonstrated significant additional benefits with the use of the bisphosphonate clodronate, for patients with primary breast cancer, when used in conjunction with standard adjuvant chemotherapy and endocrine therapy.
While a previous analysis of the study data showed that adjuvant treatment with clodronate reduced the occurrence of bone metastases and increased survival in this patient group, this new retrospective analysis showed that clodronate treatment also reduced the incidence of ...